The Spanish Association of Orphan and Ultra Orphan Drug Laboratories (AELMHU) held today the II National Conference The Future of Advanced Therapies for Rare Diseases with the aim of promoting dialogue and critical reflection among the different agents of the healthcare system in order to highlight the development of this therapeutic approach for rare diseases and to continue working together to facilitate their availability and access.

Among the main conclusions, the participants agreed on the therapeutic and social value of these advanced therapies, and the joint work of the different agents involved, which are essential to accelerate their availability and change the lives of people suffering from rare diseases.

Access the full press release here.